<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35360111</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>A Gut Feeling in Amyotrophic Lateral Sclerosis: Microbiome of Mice and Men.</ArticleTitle><Pagination><StartPage>839526</StartPage><MedlinePgn>839526</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">839526</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2022.839526</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a severely debilitating disease characterized by progressive degeneration of motor neurons. ALS etiology and pathophysiology are not well understood. It could be the consequences of complex interactions among host factors, microbiome, and the environmental factors. Recent data suggest the novel roles of intestinal dysfunction and microbiota in ALS etiology and progression. Although microbiome may indeed play a critical role in ALS pathogenesis, studies implicating innate immunity and intestinal changes in early disease pathology are limited. The gastrointestinal symptoms in the ALS patients before their diagnosis are largely ignored in the current medical practice. This review aims to explore existing evidence of gastrointestinal symptoms and progress of microbiome in ALS pathogenesis from human and animal studies. We discuss dietary, metabolites, and possible therapeutic approaches by targeting intestinal function and microbiome. Finally, we evaluate existing evidence and identify gaps in the knowledge for future directions in ALS. It is essential to understanding the microbiome and intestinal pathogenesis that determine when, where, and whether microbiome and metabolites critical to ALS progression. These studies will help us to develop more accurate diagnosis and better treatment not only for this challenging disease, but also for other neurodegenerative diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Martin, Battistini and Sun.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battistini</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Illinois at Chicago (UIC) Cancer Center, University of Illinois at Chicago, Chicago, IL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jesse Brown VA Medical Center, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 BX004824</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK105118</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK114126</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CNS - central nervous system</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">bacteria</Keyword><Keyword MajorTopicYN="N">enteric neuron</Keyword><Keyword MajorTopicYN="N">gastrointestinal digestion</Keyword><Keyword MajorTopicYN="N">metabolite</Keyword><Keyword MajorTopicYN="N">microbiome</Keyword><Keyword MajorTopicYN="N">motor neurodegeneration</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>5</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35360111</ArticleId><ArticleId IdType="pmc">PMC8963415</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2022.839526</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ballan R., Battistini C., Xavier-Santos D., Saad S. M. I. (2020). Interactions of Probiotics and Prebiotics With the Gut Microbiota. Prog. Mol. Biol. Transl. Sci. 171, 265&#x2013;300. doi: 10.1016/bs.pmbts.2020.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.pmbts.2020.03.008</ArticleId><ArticleId IdType="pubmed">32475525</ArticleId></ArticleIdList></Reference><Reference><Citation>Banack S. A., Cox P. A. (2003). Biomagnification of Cycad Neurotoxins in Flying Foxes: Implications for ALS-PDC in Guam. Neurology 61, 387&#x2013;389. doi: 10.1212/01.WNL.0000078320.18564.9F</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000078320.18564.9F</ArticleId><ArticleId IdType="pubmed">12913204</ArticleId></ArticleIdList></Reference><Reference><Citation>Baquero F., Nombela C. (2012). The Microbiome as a Human Organ. Clin. Microbiol. Infect. 18, 2&#x2013;4. doi: 10.1111/j.1469-0691.2012.03916.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2012.03916.x</ArticleId><ArticleId IdType="pubmed">22647038</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E., Bashiardes S., Shapiro H., Rothschild D., Mor U., Dori-Bachash M., et al. . (2019). Potential Roles of Gut Microbiome and Metabolites in Modulating ALS in Mice. Nature 572, 474&#x2013;480. doi: 10.1038/s41586-019-1443-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId><ArticleId IdType="pubmed">31330533</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., Hiergeist A., Adis C., Mayer B., Gessner A., Ludolph A. C., et al. . (2018). The Fecal Microbiome of ALS Patients. Neurobiol. Aging 61, 132&#x2013;137. doi: 10.1016/j.neurobiolaging.2017.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.09.023</ArticleId><ArticleId IdType="pubmed">29065369</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown K. J., Jewells V., Herfarth H., Castillo M. (2010). White Matter Lesions Suggestive of Amyotrophic Lateral Sclerosis Attributed to Celiac Disease. AJNR Am. J. Neuroradiol. 31, 880&#x2013;881. doi: 10.3174/ajnr.A1826</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A1826</ArticleId><ArticleId IdType="pmc">PMC7964190</ArticleId><ArticleId IdType="pubmed">19910450</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A., Wells M. F., Limone F., Couto A., Smith K. S., Keaney J., et al. . (2020). C9orf72 Suppresses Systemic and Neural Inflammation Induced by Gut Bacteria. Nature 582, 89&#x2013;94. doi: 10.1038/s41586-020-2288-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId><ArticleId IdType="pmc">PMC7416879</ArticleId><ArticleId IdType="pubmed">32483373</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O., Siddiqui S., Gabriely G., Lanser A. J., Dake B., Murugaiyan G., et al. . (2012). Modulating Inflammatory Monocytes With a Unique microRNA Gene Signature Ameliorates Murine ALS. J. Clin. Invest. 122, 3063&#x2013;3087. doi: 10.1172/JCI62636</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI62636</ArticleId><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Cetin H., Klickovic U., Rath J., Zulehner G., Fuzi J., Reichardt B., et al. . (2015). Associations Between Co-Medications and Survival in ALS-A Cohort Study From Austria. J. Neurol. 262, 1698&#x2013;1705. doi: 10.1007/s00415-015-7767-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7767-7</ArticleId><ArticleId IdType="pubmed">25957641</ArticleId></ArticleIdList></Reference><Reference><Citation>Cetin H., Sun J., Almqvist C., Reichardt B., Tomschik M., Zimprich F., et al. . (2020). No Association Between Proton Pump Inhibitor Use and ALS Risk: A Nationwide Nested Case-Control Study. Sci. Rep. 10, 13371. doi: 10.1038/s41598-020-70373-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-70373-8</ArticleId><ArticleId IdType="pmc">PMC7414209</ArticleId><ArticleId IdType="pubmed">32770128</ArticleId></ArticleIdList></Reference><Reference><Citation>Charchaflie R. J., Bustos Fernandez L., Perec C. J., Gonzalez E., Marzi A. (1974). Functional Studies of the Parotid and Pancreas Glands in Amyotrophic Lateral Sclerosis. J. Neurol. Neurosurg. Psychiatry 37, 863&#x2013;867. doi: 10.1136/jnnp.37.7.863</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.37.7.863</ArticleId><ArticleId IdType="pmc">PMC494795</ArticleId><ArticleId IdType="pubmed">4852110</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee I., Lu R., Zhang Y., Zhang J., Dai Y., Xia Y., et al. . (2020). Vitamin D Receptor Promotes Healthy Microbial Metabolites and Microbiome. Sci. Rep. 10, 7340. doi: 10.1038/s41598-020-64226-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-64226-7</ArticleId><ArticleId IdType="pmc">PMC7192915</ArticleId><ArticleId IdType="pubmed">32355205</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Logroscino G., Traynor B. J., Collins J., Simeone J. C., Goldstein L. A., et al. . (2013). Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature. Neuroepidemiology 41, 118&#x2013;130. doi: 10.1159/000351153</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipolat Mis M. S., Brajkovic S., Frattini E., Di Fonzo A., Corti S. (2016). Autophagy in Motor Neuron Disease: Key Pathogenetic Mechanisms and Therapeutic Targets. Mol. Cell Neurosci. 72, 84&#x2013;90. doi: 10.1016/j.mcn.2016.01.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2016.01.012</ArticleId><ArticleId IdType="pubmed">26837042</ArticleId></ArticleIdList></Reference><Reference><Citation>Deretic V., Master S., Singh S. (2008). Autophagy Gives a Nod and a Wink to the Inflammasome and Paneth Cells in Crohn&#x2019;s Disease. Dev. Cell 15, 641&#x2013;642. doi: 10.1016/j.devcel.2008.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2008.10.009</ArticleId><ArticleId IdType="pmc">PMC3725296</ArticleId><ArticleId IdType="pubmed">19000829</ArticleId></ArticleIdList></Reference><Reference><Citation>Destiny Ogbu Y. Z., Claud K. (2022). Yinglin Xia, Un Sun, Dietary Butyrate Treatment Enhances Healthy Metabolites by Longitudinal Untargeted Metabolomic Analysis in Amyotrophic Lateral Sclerosis Mice. Biorxiv. doi: 10.1101/2022.01.15.476456</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.15.476456</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vos W. M., Tilg H., Van Hul M., Cani P. D. (2022). Gut Microbiome and Health: Mechanistic Insights. Gut. doi: 10.1136gutjnl-2021-326789</Citation><ArticleIdList><ArticleId IdType="pubmed">35105664</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gioia D., Bozzi Cionci N., Baffoni L., Amoruso A., Pane M., Mogna L., et al. . (2020). A Prospective Longitudinal Study on the Microbiota Composition in Amyotrophic Lateral Sclerosis. BMC Med. 18, 153. doi: 10.1186/s12916-020-01607-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01607-9</ArticleId><ArticleId IdType="pmc">PMC7298784</ArticleId><ArticleId IdType="pubmed">32546239</ArticleId></ArticleIdList></Reference><Reference><Citation>Donatti A., Canto A. M., Godoi A. B., da Rosa D. C., Lopes-Cendes I. (2020). Circulating Metabolites as Potential Biomarkers for Neurological Disorders-Metabolites in Neurological Disorders. Metabolites 10 (10), 389. doi: 10.3390/metabo10100389</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo10100389</ArticleId><ArticleId IdType="pmc">PMC7601919</ArticleId><ArticleId IdType="pubmed">33003305</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Oudart H., Rene F., Gonzalez de Aguilar J. L., Loeffler J. P. (2004). Evidence for Defective Energy Homeostasis in Amyotrophic Lateral Sclerosis: Benefit of a High-Energy Diet in a Transgenic Mouse Model. Proc. Natl. Acad. Sci. U.S.A. 101, 11159&#x2013;11164. doi: 10.1073/pnas.0402026101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Erber A. C., Cetin H., Berry D., Schernhammer E. S. (2020). The Role of Gut Microbiota, Butyrate and Proton Pump Inhibitors in Amyotrophic Lateral Sclerosis: A Systematic Review. Int. J. Neurosci. 130, 727&#x2013;735. doi: 10.1080/00207454.2019.1702549</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207454.2019.1702549</ArticleId><ArticleId IdType="pubmed">31870202</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmaeili M. A., Panahi M., Yadav S., Hennings L., Kiaei M. (2013). Premature Death of TDP-43 (A315T) Transgenic Mice Due to Gastrointestinal Complications Prior to Development of Full Neurological Symptoms of Amyotrophic Lateral Sclerosis. Int. J. Exp. Pathol. 94, 56&#x2013;64. doi: 10.1111/iep.12006</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iep.12006</ArticleId><ArticleId IdType="pmc">PMC3575874</ArticleId><ArticleId IdType="pubmed">23317354</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X. (2016). Potential Role of Gut Microbiota and Tissue Barriers in Parkinson&#x2019;s Disease and Amyotrophic Lateral Sclerosis. Int. J. Neurosci. 126, 771&#x2013;776. doi: 10.3109/00207454.2015.1096271</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00207454.2015.1096271</ArticleId><ArticleId IdType="pubmed">26381230</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang P., Kazmi S. A., Jameson K. G., Hsiao E. Y. (2020). The Microbiome as a Modifier of Neurodegenerative Disease Risk. Cell Host Microbe 28, 201&#x2013;222. doi: 10.1016/j.chom.2020.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC7430034</ArticleId><ArticleId IdType="pubmed">32791113</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X., Wang X., Yang S., Meng F., Wang X., Wei H., et al. . (2016). Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing. Front. Microbiol. 7, 1479. doi: 10.3389/fmicb.2016.01479</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.01479</ArticleId><ArticleId IdType="pmc">PMC5028383</ArticleId><ArticleId IdType="pubmed">27703453</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer-Donato A., Contreras A., Frago L. M., Chowen J. A., Fernandez-Martos C. M. (2021). Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS). Int. J. Mol. Sci. 22 (19), 10305. doi: 10.3390/ijms221910305</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910305</ArticleId><ArticleId IdType="pmc">PMC8508891</ArticleId><ArticleId IdType="pubmed">34638645</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C., Guo K., Murdock B. J., Paez-Colasante X., Bassis C. M., Mikhail K. A., et al. . (2019). Temporal Evolution of the Microbiome, Immune System and Epigenome With Disease Progression in ALS Mice. Dis. Model Mech. 13 (2), dmm041947. doi: 10.1242/dmm.041947</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.041947</ArticleId><ArticleId IdType="pmc">PMC6906635</ArticleId><ArticleId IdType="pubmed">31597644</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleck A. K., Hucke S., Teipel F., Eschborn M., Janoschka C., Liebmann M., et al. . (2021). Dietary Conjugated Linoleic Acid Links Reduced Intestinal Inflammation to Amelioration of CNS Autoimmunity. Brain 144 (4), 1152&#x2013;1166. doi: 10.1093/brain/awab040</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab040</ArticleId><ArticleId IdType="pmc">PMC8105041</ArticleId><ArticleId IdType="pubmed">33899089</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadoth A., Nefussy B., Bleiberg M., Klein T., Artman I., Drory V. E. (2015). Transglutaminase 6 Antibodies in the Serum of Patients With Amyotrophic Lateral Sclerosis. JAMA Neurol. 72, 676&#x2013;681. doi: 10.1001/jamaneurol.2015.48</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.48</ArticleId><ArticleId IdType="pubmed">25867286</ArticleId></ArticleIdList></Reference><Reference><Citation>Group A. L. S. U. (2016). ALSUntangled No. 32: Gluten-Free Diet. Amyotroph. Lateral Scler. Frontotemporal Degener. 17, 307&#x2013;309. doi: 10.3109/21678421.2015.1096496</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1096496</ArticleId><ArticleId IdType="pubmed">26473662</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Wang Q., Zhang K., An T., Shi P., Li Z., et al. . (2012). HO-1 Induction in Motor Cortex and Intestinal Dysfunction in TDP-43 A315T Transgenic Mice. Brain Res. 1460, 88&#x2013;95. doi: 10.1016/j.brainres.2012.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.04.003</ArticleId><ArticleId IdType="pubmed">22578468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ham H., Lee B. I., Oh H. J., Park S. H., Kim J. S., Park J. M., et al. . (2017). A Case of Celiac Disease With Neurologic Manifestations Misdiagnosed as Amyotrophic Lateral Sclerosis. Intest. Res. 15, 540&#x2013;542. doi: 10.5217/ir.2017.15.4.540</Citation><ArticleIdList><ArticleId IdType="doi">10.5217/ir.2017.15.4.540</ArticleId><ArticleId IdType="pmc">PMC5683987</ArticleId><ArticleId IdType="pubmed">29142524</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatzipetros T., Bogdanik L. P., Tassinari V. R., Kidd J. D., Moreno A. J., Davis C., et al. . (2014). C57BL/6J Congenic Prp-TDP43A315T Mice Develop Progressive Neurodegeneration in the Myenteric Plexus of the Colon Without Exhibiting Key Features of ALS. Brain Res. 1584, 59&#x2013;72. doi: 10.1016/j.brainres.2013.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2013.10.013</ArticleId><ArticleId IdType="pubmed">24141148</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdewyn S., Cirillo C., Van Den Bosch L., Robberecht W., Vanden Berghe P., Van Damme P. (2014). Prevention of Intestinal Obstruction Reveals Progressive Neurodegeneration in Mutant TDP-43 (A315T) Mice. Mol. Neurodegener. 9, 24. doi: 10.1186/1750-1326-9-24</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-9-24</ArticleId><ArticleId IdType="pmc">PMC4088917</ArticleId><ArticleId IdType="pubmed">24938805</ArticleId></ArticleIdList></Reference><Reference><Citation>Hertzberg V. S., Singh H., Fournier C. N., Moustafa A., Polak M., Kuelbs C. A., et al. . (2022). Gut Microbiome Differences Between Amyotrophic Lateral Sclerosis Patients and Spouse Controls. Amyotroph Lateral Scler Frontotemporal Degener 23, 91&#x2013;99. doi: 10.1080/21678421.2021.1904994</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1904994</ArticleId><ArticleId IdType="pubmed">33818222</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Xu H., Luo Q., He J., Li M., Chen H., et al. . (2019). Fecal Microbiota Transplantation to Treat Parkinson&#x2019;s Disease With Constipation: A Case Report. Med. (Baltimore) 98, e16163. doi: 10.1097/MD.0000000000016163</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000016163</ArticleId><ArticleId IdType="pmc">PMC6616439</ArticleId><ArticleId IdType="pubmed">31261545</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang D. W., Adams J. B., Coleman D. M., Pollard E. L., Maldonado J., McDonough-Means S., et al. . (2019). Long-Term Benefit of Microbiota Transfer Therapy on Autism Symptoms and Gut Microbiota. Sci. Rep. 9, 5821. doi: 10.1038/s41598-019-42183-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-42183-0</ArticleId><ArticleId IdType="pmc">PMC6456593</ArticleId><ArticleId IdType="pubmed">30967657</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang D. W., Adams J. B., Gregory A. C., Borody T., Chittick L., Fasano A., et al. . (2017). Microbiota Transfer Therapy Alters Gut Ecosystem and Improves Gastrointestinal and Autism Symptoms: An Open-Label Study. Microbiome 5, 10. doi: 10.1186/s40168-016-0225-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-016-0225-7</ArticleId><ArticleId IdType="pmc">PMC5264285</ArticleId><ArticleId IdType="pubmed">28122648</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon H. S., Koh S. H. (2020). Neuroinflammation in Neurodegenerative Disorders: The Roles of Microglia and Astrocytes. Transl. Neurodegener. 9, 42. doi: 10.1186/s40035-020-00221-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-020-00221-2</ArticleId><ArticleId IdType="pmc">PMC7689983</ArticleId><ArticleId IdType="pubmed">33239064</ArticleId></ArticleIdList></Reference><Reference><Citation>Labarre A., Guitard E., Parker J. A. (2017). Variation of Gut Microbiome Rescues Paralysis and Neurodegeneration Profiles in C. Elegans ALS Models. Amyotrophic Lateral Scler Frontotemporal Degener, 245&#x2013;246.</Citation></Reference><Reference><Citation>Lee S. H., Yang E. J. (2018). Relationship Between Liver Pathology and Disease Progression in a Murine Model of Amyotrophic Lateral Sclerosis. Neurodegener. Dis. 18, 200&#x2013;207. doi: 10.1159/000491392</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000491392</ArticleId><ArticleId IdType="pubmed">30130789</ArticleId></ArticleIdList></Reference><Reference><Citation>Luesma M. J., Cantarero I., &#xc1;lvarez-Dotu J. M., Santander S., Junquera C. (2014). New Insights Into C-Ret Signalling Pathway in the Enteric Nervous System and its Relationship With ALS. BioMed. Res. Int. 2014, 328348. doi: 10.1155/2014/328348</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/328348</ArticleId><ArticleId IdType="pmc">PMC4020535</ArticleId><ArticleId IdType="pubmed">24868525</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R., Zhang Y. G., Xia Y., Zhang J., Kaser A., Blumberg R., et al. . (2021). Paneth Cell Alertness to Pathogens Maintained by Vitamin D Receptors. Gastroenterology 160, 1269&#x2013;1283. doi: 10.1053/j.gastro.2020.11.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.11.015</ArticleId><ArticleId IdType="pmc">PMC8808465</ArticleId><ArticleId IdType="pubmed">33217447</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J., Amedei A., Cammarota G., Niccolai E., Zucchi E., D&#x2019;Amico R., et al. . (2019). FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis. Front. Neurol. 10, 1021. doi: 10.3389/fneur.2019.01021</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.01021</ArticleId><ArticleId IdType="pmc">PMC6763586</ArticleId><ArticleId IdType="pubmed">31620079</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L., Mogna L., De Marchi F., Amoruso A., Pane M., Aloisio I., et al. . (2018). Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies. J. Clin. Gastroenterol. 52, S68&#x2013;S70. Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition &amp; Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017. doi: 10.1097/MCG.0000000000001042</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCG.0000000000001042</ArticleId><ArticleId IdType="pubmed">29782468</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe P. A., Henderson R. D. (2011). The Role of Immune and Inflammatory Mechanisms in ALS. Curr. Mol. Med. 11, 246&#x2013;254. doi: 10.2174/156652411795243450</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652411795243450</ArticleId><ArticleId IdType="pmc">PMC3182412</ArticleId><ArticleId IdType="pubmed">21375489</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R. G., Mitchell J. D., Moore D. H. (2012). Riluzole for Amyotrophic Lateral Sclerosis (ALS)/motor Neuron Disease (MND). Cochrane Database Syst. Rev., CD001447. doi: 10.1002/14651858.CD001447.pub3</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001447.pub3</ArticleId><ArticleId IdType="pmc">PMC7055506</ArticleId><ArticleId IdType="pubmed">22419278</ArticleId></ArticleIdList></Reference><Reference><Citation>Minalyan A., Gabrielyan L., Scott D., Jacobs J., Pisegna J. R. (2017). The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors. Curr. Gastroenterol. Rep. 19, 42. doi: 10.1007/s11894-017-0577-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11894-017-0577-6</ArticleId><ArticleId IdType="pmc">PMC5621514</ArticleId><ArticleId IdType="pubmed">28733944</ArticleId></ArticleIdList></Reference><Reference><Citation>Murch S. J., Cox P. A., Banack S. A., Steele J. C., Sacks O. W. (2004). Occurrence of Beta-Methylamino-L-Alanine (BMAA) in ALS/PDC Patients From Guam. Acta Neurol Scand 110, 267&#x2013;269. doi: 10.1111/j.1600-0404.2004.00320.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2004.00320.x</ArticleId><ArticleId IdType="pubmed">15355492</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano Y., Hirayama K., Terao K. (1987). Hepatic Ultrastructural Changes and Liver Dysfunction in Amyotrophic Lateral Sclerosis. Arch. Neurol. 44, 103&#x2013;106. doi: 10.1001/archneur.1987.00520130079022</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1987.00520130079022</ArticleId><ArticleId IdType="pubmed">3800708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo S. T., Restuadi R., McCrae A. F., Van Eijk R. P., Garton F., Henderson R. D., et al. . (2020). Progression and Survival of Patients With Motor Neuron Disease Relative to Their Fecal Microbiota. Amyotroph. Lateral Scler. Frontotemporal Degener. 21, 549&#x2013;562. doi: 10.1080/21678421.2020.1772825</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1772825</ArticleId><ArticleId IdType="pubmed">32643435</ArticleId></ArticleIdList></Reference><Reference><Citation>Niccolai E., Di Pilato V., Nannini G., Baldi S., Russo E., Zucchi E., et al. . (2021). The Gut Microbiota-Immunity Axis in ALS: A Role in Deciphering Disease Heterogeneity? Biomedicines 9, 1&#x2013;17. doi: 10.3390/biomedicines9070753</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9070753</ArticleId><ArticleId IdType="pmc">PMC8301418</ArticleId><ArticleId IdType="pubmed">34209688</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A., Kenna K. P., Renton A. E., Ticozzi N., Faghri F., Chia R., et al. . (2018). Genome-Wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron 97, 1268&#x2013;126+. doi: 10.1016/j.neuron.2018.02.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Niesler B., Kuerten S., Demir I. E., Schafer K. H. (2021). Disorders of the Enteric Nervous System - a Holistic View. Nat. Rev. Gastroenterol. Hepatol. 18, 393&#x2013;410. doi: 10.1038/s41575-020-00385-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-020-00385-2</ArticleId><ArticleId IdType="pubmed">33514916</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak V., Rogelj B., Zupunski V. (2021). Therapeutic Potential of Polyphenols in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Antioxidants (Basel) 10 (8), 1328. doi: 10.3390/antiox10081328</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10081328</ArticleId><ArticleId IdType="pmc">PMC8389294</ArticleId><ArticleId IdType="pubmed">34439576</ArticleId></ArticleIdList></Reference><Reference><Citation>Nubling G. S., Mie E., Bauer R. M., Hensler M., Lorenzl S., Hapfelmeier A., et al. . (2014). Increased Prevalence of Bladder and Intestinal Dysfunction in Amyotrophic Lateral Sclerosis. Amyotroph. Lateral Scler. Frontotemporal. Degener. 15, 174&#x2013;179. doi: 10.3109/21678421.2013.868001</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.868001</ArticleId><ArticleId IdType="pubmed">24479577</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogbu D., Xia E., Sun J. (2020). Gut Instincts: Vitamin D/vitamin D Receptor and Microbiome in Neurodevelopment Disorders. Open Biol. 10, 200063. doi: 10.1098/rsob.200063</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200063</ArticleId><ArticleId IdType="pmc">PMC7574554</ArticleId><ArticleId IdType="pubmed">32634371</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Macklin E. A., Hendrix S., Berry J. D., Elliott M. A., Maiser S., et al. . (2020). Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis. N Engl. J. Med. 383, 919&#x2013;930. doi: 10.1056/NEJMoa1916945</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1916945</ArticleId><ArticleId IdType="pubmed">32877582</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape J. A., Grose J. H. (2020). The Effects of Diet and Sex in Amyotrophic Lateral Sclerosis. Rev. Neurol. (Paris) 176, 301&#x2013;315. doi: 10.1016/j.neurol.2019.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2019.09.008</ArticleId><ArticleId IdType="pmc">PMC8915943</ArticleId><ArticleId IdType="pubmed">32147204</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Rothstein J. D. (2015). Rodent Models of Amyotrophic Lateral Sclerosis. Curr. Protoc. Pharmacol. 69, 5 67 1&#x2013;5 67 21. doi: 10.1002/0471141755.ph0567s69</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471141755.ph0567s69</ArticleId><ArticleId IdType="pmc">PMC4562058</ArticleId><ArticleId IdType="pubmed">26344214</ArticleId></ArticleIdList></Reference><Reference><Citation>Quick D. T., Greer M. (1967). Pancreatic Dysfunction in Patients With Amyotrophic Lateral Sclerosis. Neurology 17, 112&#x2013;116. doi: 10.1212/WNL.17.2.112</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.17.2.112</ArticleId><ArticleId IdType="pubmed">6066871</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao M., Gershon M. D. (2016). The Bowel and Beyond: The Enteric Nervous System in Neurological Disorders. Nat. Rev. Gastroenterol. Hepatol. 13, 517&#x2013;528. doi: 10.1038/nrgastro.2016.107</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2016.107</ArticleId><ArticleId IdType="pmc">PMC5005185</ArticleId><ArticleId IdType="pubmed">27435372</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts A. L., Johnson N. J., Cudkowicz M. E., Eum K. D., Weisskopf M. G. (2016). Job-Related Formaldehyde Exposure and ALS Mortality in the USA. J.&#xa0;Neurol. Neurosurg Psychiatry 87, 786&#x2013;788. doi: 10.1136/jnnp-2015-310750</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310750</ArticleId><ArticleId IdType="pmc">PMC4738165</ArticleId><ArticleId IdType="pubmed">26169306</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowin J., Xia Y., Jung B., Sun J. (2017). Gut Inflammation and Dysbiosis in Human Motor Neuron Disease. Physiol. Rep. 5, 1&#x2013;6. doi: 10.14814/phy2.13443</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.13443</ArticleId><ArticleId IdType="pmc">PMC5617930</ArticleId><ArticleId IdType="pubmed">28947596</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabel C. E., Boyle P. J., Loytonen M., Gatrell A. C., Jokelainen M., Flowerdew R., et al. . (2003). Spatial Clustering of Amyotrophic Lateral Sclerosis in Finland at Place of Birth and Place of Death. Am. J. Epidemiol. 157, 898&#x2013;905. doi: 10.1093/aje/kwg090</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwg090</ArticleId><ArticleId IdType="pubmed">12746242</ArticleId></ArticleIdList></Reference><Reference><Citation>Solanki I., Parihar P., Mansuri M. L., Parihar M. S. (2015). Flavonoid-Based Therapies in the Early Management of Neurodegenerative Diseases. Adv. Nutr. 6, 64&#x2013;72. doi: 10.3945/an.114.007500</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/an.114.007500</ArticleId><ArticleId IdType="pmc">PMC4288281</ArticleId><ArticleId IdType="pubmed">25593144</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Zhan Y., Mariosa D., Larsson H., Almqvist C., Ingre C., et al. . (2019). Antibiotics Use and Risk of Amyotrophic Lateral Sclerosis in Sweden. Eur. J. Neurol. 26, 1355&#x2013;1361. doi: 10.1111/ene.13986</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13986</ArticleId><ArticleId IdType="pubmed">31087715</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedeschi V., Petrozziello T., Secondo A. (2019). Calcium Dyshomeostasis and Lysosomal Ca(2+) Dysfunction in Amyotrophic Lateral Sclerosis. Cells 8 (10), 1216. doi: 10.3390/cells8101216</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8101216</ArticleId><ArticleId IdType="pmc">PMC6829585</ArticleId><ArticleId IdType="pubmed">31597311</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortelli R., Zecca C., Piccininni M., Benmahamed S., Dell&#x2019;Abate M. T., Barulli M. R., et al. . (2020). Plasma Inflammatory Cytokines Are Elevated in ALS. Front. Neurol. 11, 552295. doi: 10.3389/fneur.2020.552295</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.552295</ArticleId><ArticleId IdType="pmc">PMC7691268</ArticleId><ArticleId IdType="pubmed">33281700</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnbull J. (2020). Sodium Phenylbutyrate-Taurursodiol for ALS. N. Engl. J. Med. 383, 2293&#x2013;2294. doi: 10.1056/NEJMc2030710</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2030710</ArticleId><ArticleId IdType="pubmed">33264553</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M. R., Al-Chalabi A., Chio A., Hardiman O., Kiernan M. C., Rohrer J. D., et al. . (2017). Genetic Screening in Sporadic ALS and FTD. J. Neurol Neurosurg Psychiatry 88, 1042&#x2013;1044. doi: 10.1136/jnnp-2017-315995</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315995</ArticleId><ArticleId IdType="pmc">PMC5740553</ArticleId><ArticleId IdType="pubmed">28642287</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M. R., Chohan G., Quaghebeur G., Greenhall R. C., Hadjivassiliou M., Talbot K. (2007). A Case of Celiac Disease Mimicking Amyotrophic Lateral Sclerosis. Nat. Clin. Pract. Neurol. 3, 581&#x2013;584. doi: 10.1038/ncpneuro0631</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpneuro0631</ArticleId><ArticleId IdType="pubmed">17914346</ArticleId></ArticleIdList></Reference><Reference><Citation>Utterback R. A., Cummins A. J., Cape C. A., Goldenberg J. (1970). Pancreatic Function in Amyotrophic Lateral Sclerosis. J. Neurol. Neurosurg Psychiatry 33, 544&#x2013;547. doi: 10.1136/jnnp.33.4.544</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.33.4.544</ArticleId><ArticleId IdType="pmc">PMC493517</ArticleId><ArticleId IdType="pubmed">5505684</ArticleId></ArticleIdList></Reference><Reference><Citation>Volk A. E., Weishaupt J. H., Andersen P. M., Ludolph A. C., Kubisch C. (2018). Current Knowledge and Recent Insights Into the Genetic Basis of Amyotrophic Lateral Sclerosis. Med. Genet-Berlin 30, 252&#x2013;258. doi: 10.1007/s11825-018-0185-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11825-018-0185-3</ArticleId><ArticleId IdType="pmc">PMC6132774</ArticleId><ArticleId IdType="pubmed">30220791</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M. D., Little J., Gomes J., Cashman N. R., Krewski D. (2017). Identification of Risk Factors Associated With Onset and Progression of Amyotrophic Lateral Sclerosis Using Systematic Review and Meta-Analysis. Neurotoxicology 61, 101&#x2013;130. doi: 10.1016/j.neuro.2016.06.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2016.06.015</ArticleId><ArticleId IdType="pubmed">27377857</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisskopf M. G., Morozova N., O&#x2019;Reilly E. J., McCullough M. L., Calle E. E., Thun M. J., et al. . (2009). Prospective Study of Chemical Exposures and Amyotrophic Lateral Sclerosis. J. Neurol. Neurosurg. Psychiatry 80, 558&#x2013;561. doi: 10.1136/jnnp.2008.156976</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2008.156976</ArticleId><ArticleId IdType="pmc">PMC2765376</ArticleId><ArticleId IdType="pubmed">19372290</ArticleId></ArticleIdList></Reference><Reference><Citation>Whipps J., Lewis K., Cooke R. (1988). &#x201c;Mycoparasitism and Plant Disease Control,&#x201d; in Fungi in Biological Control Systems. Ed. M B. (Manchester: Manchester University Press; ), 161&#x2013;187.</Citation></Reference><Reference><Citation>Wingate D. (1999). Gastrointestinal Dysfunction in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 1, 2.</Citation><ArticleIdList><ArticleId IdType="pubmed">12365062</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S., Yi J., Zhang Y. G., Zhou J., Sun J. (2015). Leaky Intestine and Impaired Microbiome in an Amyotrophic Lateral Sclerosis Mouse Model. Physiol. Rep. 3, 1&#x2013;10. doi: 10.14814/phy2.12356</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.12356</ArticleId><ArticleId IdType="pmc">PMC4425962</ArticleId><ArticleId IdType="pubmed">25847918</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H. M., Huang H. L., Zhou Y. L., Zhao H. L., Xu J., Shou D. W., et al. . (2021). Fecal Microbiota Transplantation: A New Therapeutic Attempt From the Gut to the Brain. Gastroenterol. Res. Pract. 2021, 6699268. doi: 10.1155/2021/6699268</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6699268</ArticleId><ArticleId IdType="pmc">PMC7826222</ArticleId><ArticleId IdType="pubmed">33510784</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanez M., Galan L., Matias-Guiu J., Vela A., Guerrero A., Garcia A. G. (2011). CSF From Amyotrophic Lateral Sclerosis Patients Produces Glutamate Independent Death of Rat Motor Brain Cortical Neurons: Protection by Resveratrol But Not Riluzole. Brain Res. 1423, 77&#x2013;86. doi: 10.1016/j.brainres.2011.09.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2011.09.025</ArticleId><ArticleId IdType="pubmed">21983205</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Q., Shen J., Chen K., Zhou J., Liao Q., Lu K., et al. . (2020). The Alteration of Gut Microbiome and Metabolism in Amyotrophic Lateral Sclerosis Patients. Sci. Rep. 10, 12998. doi: 10.1038/s41598-020-69845-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-69845-8</ArticleId><ArticleId IdType="pmc">PMC7398913</ArticleId><ArticleId IdType="pubmed">32747678</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai C. D., Zheng J. J., An B. C., Huang H. F., Tan Z. C. (2019). Intestinal Microbiota Composition in Patients With Amyotrophic Lateral Sclerosis: Establishment of Bacterial and Archaeal Communities Analyses. Chin. Med. J. (Engl) 132, 1815&#x2013;1822. doi: 10.1097/CM9.0000000000000351</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000000351</ArticleId><ArticleId IdType="pmc">PMC6759115</ArticleId><ArticleId IdType="pubmed">31306225</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. G., Lu R., Xia Y., Zhou D., Petrof E., Claud E. C., et al. . (2019). Lack of Vitamin D Receptor Leads to Hyperfunction of Claudin-2 in Intestinal Inflammatory Responses. Inflamm. Bowel Dis. 25, 97&#x2013;110. doi: 10.1093/ibd/izy292</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izy292</ArticleId><ArticleId IdType="pmc">PMC6290786</ArticleId><ArticleId IdType="pubmed">30289450</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R., Miller R. G., Gascon R., Champion S., Katz J., Lancero M., et al. . (2009). Circulating Endotoxin and Systemic Immune Activation in Sporadic Amyotrophic Lateral Sclerosis (sALS). J. Neuroimmunol. 206, 121&#x2013;124. doi: 10.1016/j.jneuroim.2008.09.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2008.09.017</ArticleId><ArticleId IdType="pmc">PMC2995297</ArticleId><ArticleId IdType="pubmed">19013651</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. G., Ogbu D., Garrett S., Xia Y., Sun J. (2021). Aberrant Enteric Neuromuscular System and Dysbiosis in Amyotrophic Lateral Sclerosis. Gut Microbes 13, 1996848. doi: 10.1080/19490976.2021.1996848</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.1996848</ArticleId><ArticleId IdType="pmc">PMC8632307</ArticleId><ArticleId IdType="pubmed">34812107</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. G., Wu S., Sun J. (2013). Vitamin D, Vitamin D Receptor, and Tissue Barriers. Tissue Barriers 1 (1). doi: 10.4161/tisb.23118</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/tisb.23118</ArticleId><ArticleId IdType="pmc">PMC3865708</ArticleId><ArticleId IdType="pubmed">24358453</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. G., Wu S., Yi J., Xia Y., Jin D., Zhou J., et al. . (2017). Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis. Clin. Ther. 39, 322&#x2013;336. doi: 10.1016/j.clinthera.2016.12.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2016.12.014</ArticleId><ArticleId IdType="pmc">PMC5344195</ArticleId><ArticleId IdType="pubmed">28129947</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhuang Z., Zhang G., Huang T., Fan D. (2022). Assessment of Bidirectional Relationships Between 98 Genera of the Human Gut Microbiota and Amyotrophic Lateral Sclerosis: A 2-Sample Mendelian Randomization Study. BMC Neurol. 22, 8. doi: 10.1186/s12883-021-02522-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-021-02522-z</ArticleId><ArticleId IdType="pmc">PMC8721912</ArticleId><ArticleId IdType="pubmed">34979977</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann M., Zimmermann-Kogadeeva M., Wegmann R., Goodman A. L. (2019). Mapping Human Microbiome Drug Metabolism by Gut Bacteria and Their Genes. Nature 570, 462&#x2013;467. doi: 10.1038/s41586-019-1291-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1291-3</ArticleId><ArticleId IdType="pmc">PMC6597290</ArticleId><ArticleId IdType="pubmed">31158845</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>